LLY

836.99

-0.74%↓

UNH

515.83

+1.16%↑

JNJ

163.37

+0.29%↑

ABBV

209.84

-0.76%↓

NVO

76.76

-2.48%↓

LLY

836.99

-0.74%↓

UNH

515.83

+1.16%↑

JNJ

163.37

+0.29%↑

ABBV

209.84

-0.76%↓

NVO

76.76

-2.48%↓

LLY

836.99

-0.74%↓

UNH

515.83

+1.16%↑

JNJ

163.37

+0.29%↑

ABBV

209.84

-0.76%↓

NVO

76.76

-2.48%↓

LLY

836.99

-0.74%↓

UNH

515.83

+1.16%↑

JNJ

163.37

+0.29%↑

ABBV

209.84

-0.76%↓

NVO

76.76

-2.48%↓

LLY

836.99

-0.74%↓

UNH

515.83

+1.16%↑

JNJ

163.37

+0.29%↑

ABBV

209.84

-0.76%↓

NVO

76.76

-2.48%↓

Search

Amarin Corp PLC ADR

Cerrado

0.45 4.65

Resumen

Variación precio

24h

Actual

Mínimo

0.45

Máximo

0.46

Métricas clave

By Trading Economics

Ingresos

-23M

-49M

Ventas

20M

62M

BPA

-0.02

Margen de beneficio

-78.031

Empleados

275

EBITDA

-13M

-37M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+117.39% upside

Dividendos

By Dow Jones

Próximas Ganancias

30 abr 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-65M

172M

Apertura anterior

-4.2

Cierre anterior

0.45

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

Amarin Corp PLC ADR Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

21 mar 2025, 21:58 UTC

Adquisiciones, fusiones, absorciones

Global Business Travel Group Cuts Price of Deal for Rival CWT

21 mar 2025, 16:31 UTC

Principales Movimientos del Mercado

Boeing Shares Rise After Winning $20 Billion Air Force Contract

21 mar 2025, 23:02 UTC

Adquisiciones, fusiones, absorciones

Ranking the S&P 500s Most Defensive Stocks -- Barrons.com

21 mar 2025, 22:15 UTC

Adquisiciones, fusiones, absorciones

Riot Platforms: Unit Will Provide $185M to Rhodium on Deal Close >RIOT

21 mar 2025, 22:13 UTC

Adquisiciones, fusiones, absorciones

Riot Platforms: Motion Filed to Approve Settlement in Rhodium's Bankruptcy Case

21 mar 2025, 22:12 UTC

Adquisiciones, fusiones, absorciones

Riot Platforms Enters Non-Binding Term Sheet to Buy Certain Assets of Rhodium Encore >RIOT

21 mar 2025, 22:03 UTC

Principales Noticias

Trump to Announce Multibillion-Dollar Jet Fighter -- 4th Update

21 mar 2025, 21:05 UTC

Principales Noticias

The Score: Nvidia, Tesla, Nike and More Stocks That Defined the Week -- WSJ

21 mar 2025, 20:50 UTC

Charlas de Mercado
Ganancias

Auto & Transport Roundup: Market Talk

21 mar 2025, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

21 mar 2025, 20:24 UTC

Principales Noticias

Major Indexes Stage Late Rally -- WSJ

21 mar 2025, 20:01 UTC

Principales Noticias

Columbia Yields to Trump in Battle Over Federal Funding -- WSJ

21 mar 2025, 19:40 UTC

Charlas de Mercado

Walmart's Beauty Marketplace Push Puts Ulta Beauty at Risk -- Market Talk

21 mar 2025, 19:29 UTC

Charlas de Mercado

Oil Futures Post Moderate Weekly Gains -- Market Talk

21 mar 2025, 19:09 UTC

Charlas de Mercado

U.S. Natural Gas Futures Grapple With $4 Level -- Market Talk

21 mar 2025, 19:02 UTC

Charlas de Mercado

Gold Eases to End Record-Setting Week -- Market Talk

21 mar 2025, 18:52 UTC

Charlas de Mercado

Telus Downgraded on Leverage, Cash Flow, Dividend Concerns -- Market Talk

21 mar 2025, 18:49 UTC

Principales Noticias

Trump to Announce Multibillion-Dollar Jet Fighter -- Third Update

21 mar 2025, 18:39 UTC

Charlas de Mercado
Ganancias

Nike's Aggressive Discounting Of Classics Could Damage Brand -- Market Talk

21 mar 2025, 18:07 UTC

Principales Noticias

Major Indexes Swing Around the Flatline -- WSJ

21 mar 2025, 18:07 UTC

Charlas de Mercado
Ganancias

Nike's Focus On Hot New Products May Not Offset Decline In Classic Styles -- Market Talk

21 mar 2025, 17:41 UTC

Charlas de Mercado
Ganancias

Nike's Turnaround Messaging May Add Some Confusion -- Market Talk

21 mar 2025, 17:41 UTC

Principales Noticias

Trump to Announce Multibillion-Dollar Jet Fighter -- Second Update

21 mar 2025, 17:41 UTC

Charlas de Mercado
Ganancias

Global Equities Roundup: Market Talk

21 mar 2025, 17:17 UTC

Charlas de Mercado

U.S. Oil Rig Count Slips By One to 486 -- Market Talk

21 mar 2025, 17:06 UTC

Charlas de Mercado

Bitcoin Treads Water After Trump Address -- Market Talk

21 mar 2025, 16:54 UTC

Charlas de Mercado
Ganancias

FedEx Assumed an Industrial Ramp Up That Didn't Come -- Market Talk

21 mar 2025, 16:40 UTC

Charlas de Mercado

Mexican Inflation Likely Slowed in Early March -- Market Talk

21 mar 2025, 16:25 UTC

Principales Noticias

Dow, S&P 500 Fall -- WSJ

21 mar 2025, 16:17 UTC

Principales Noticias

NY Fed's Williams Says 'Uncertainty Is High,' Sees Slower GDP Growth -- Barrons.com

Comparación entre iguales

Cambio de precio

Amarin Corp PLC ADR Esperado

Precio Objetivo

By TipRanks

117.39% repunte

Estimación a 12 meses

Media 1 USD  117.39%

Máximo 1 USD

Mínimo 1 USD

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Amarin Corp PLC ADR Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

1 ratings

0

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

0.4005 / 0.4704Soporte y Resistencia

Corto Plazo

Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

No Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Amarin Corp PLC ADR

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.